首页> 外文期刊>Urology >Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.
【24h】

Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.

机译:对于前列腺癌检测中可重复应用过渡区的前列腺特异性抗原密度,必须使用体积特异性阈值。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: To determine the effect of prostate volume on the specificity of prostate-specific antigen density (PSAD) and PSAD of the transition zone (PSA-TZ) in the detection of prostate cancer. METHODS: Between February 1994 and April 1998, transrectal ultrasound-guided prostate needle biopsies were performed in 235 men with serum prostate-specific antigen (PSA) levels between 4.0 and 10.0 ng/mL. The PSAD and PSA-TZ specificities were calculated at 95% sensitivity cutoff levels generated from the whole group, as well as from cohorts stratified by transition zone index or prostate volume. RESULTS: Statistical significance was noted between the benign (n = 176) and prostate cancer (n = 59) groups for all tested PSA parameters. At 95% sensitivity, PSA-TZ carried a specificity of 37.5% compared with 29.6% for PSAD. When applying a single 95% sensitivity cutoff derived from the entire group to individual volume-stratified cohorts, the specificity decreased to 0% in glands less than 30 g in size. A 95% sensitivity PSA-TZ cutoff generated individually for volume-stratified cohorts of glands less than 30, 30 to 40, and 40 to 60 g resulted in more consistent specificity of 28.2%, 35.2%, and 45.7% for each cohort, respectively. CONCLUSIONS: Unlike whole group-derived cutoffs, the use of volume-specific PSA-TZ cutoffs allows consistently high specificity in all volume-stratified cohorts. The discrepancies in the PSA-TZ and PSAD specificities in published reports are likely due to the application of published cutoffs to populations of differing prostate volumes. The use of volume-specific cutoffs results in reproducible specificity in populations with differing prostate volume distribution, and thereby definitively resolves the differences in PSA-TZ specificity reported in published reports.
机译:目的:确定前列腺体积对前列腺特异性抗原密度(PSAD)和过渡区PSAD(PSA-TZ)检测前列腺癌的特异性的影响。方法:在1994年2月至1998年4月之间,对235名血清前列腺特异性抗原(PSA)水平在4.0至10.0 ng / mL之间的男性进行了经直肠超声引导的前列腺穿刺活检。 PSAD和PSA-TZ特异性的计算是根据整个小组以及按过渡区指数或前列腺体积分层的人群得出的95%敏感性临界水平。结果:对于所有测试的PSA参数,在良性组(n = 176)和前列腺癌(n = 59)组之间有统计学意义。在灵敏度为95%时,PSA-TZ的特异性为37.5%,而PSAD为29.6%。当将来自整个研究组的单个95%敏感性标准应用于个体体积分层的队列时,在大小小于30 g的腺体中,特异性降低至0%。对于体积分层的小于30、30至40和40至60 g的腺体,分别产生95%的PSA-TZ敏感性临界值,导致每个队列的特异性一致性分别为28.2%,35.2%和45.7% 。结论:与整个小组衍生的临界值不同,使用体积特异性PSA-TZ临界值可以在所有体积分层的队列中始终保持高特异性。已发表的报告中PSA-TZ和PSAD特异性的差异可能是由于已发表的临界值应用于不同前列腺体积的人群。使用体积特异性截止值可在具有不同前列腺体积分布的人群中产生可再现的特异性,从而最终解决已发表报告中报道的PSA-TZ特异性差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号